Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Debt (2021 - 2023)

Standard Biotools has reported Non-Current Debt over the past 5 years, most recently at $3.4 million for Q4 2023.

  • Quarterly Non-Current Debt fell 58.34% to $3.4 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2023, down 58.34% year-over-year, with the annual reading at $3.4 million for FY2023, 58.34% down from the prior year.
  • Non-Current Debt was $3.4 million for Q4 2023 at Standard Biotools, down from $4.6 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $10.2 million in Q2 2022 and troughed at $3.4 million in Q4 2023.
  • The 3-year median for Non-Current Debt is $8.8 million (2022), against an average of $7.9 million.
  • Year-over-year, Non-Current Debt fell 6.14% in 2022 and then plummeted 58.34% in 2023.
  • A 3-year view of Non-Current Debt shows it stood at $10.0 million in 2021, then fell by 18.46% to $8.2 million in 2022, then tumbled by 58.34% to $3.4 million in 2023.
  • Per Business Quant, the three most recent readings for LAB's Non-Current Debt are $3.4 million (Q4 2023), $4.6 million (Q3 2023), and $5.8 million (Q2 2023).